Thank you for your interest in the Fighting Chronic Disease Summit! Space is limited so please register today. We ask that participation be limited to max. three people/company.

AGENDA

The FCD Summit will be two busy days to make the most of your time but will include enough lengthy coffee breaks for you to mingle with other industry experts. The event will begin at 08:45 on Wednesday, 23 September, and buses will take attendees to Geneva Airport on Thursday at 16:30.

Topics will include:

  • Healthier Planet for Healthier Patients: a Matter of Choice?  | Sanofi
  • Predictive Tolerance Analysis: Robust Medical Device Functionality | Nolato
  • Designing Injection Devices: From Needles to Needle-Free: The Human Factors Story Behind Drug Delivery Innovation | Clarimed
  • Producing Hollow Polymer Microneedles Using Laser Ablated Molds in an Injection Molding Process | University of Leuven
  • Speed to Market: How can Digital Assistants in Injection Molding Machines and AI Help Shorten the Validation Phase? | Engel
  • Engineering Efficiency in Medical Manufacturing: How Process‑stable Technologies Accelerate Quality, Speed and Cost Performance | Ewikon
  • How Modern Protoyping Accelerates Drug delivery Device Development | FRP / IGS-Gebojagema
  • Topic tbd | Eli Lilly
  • …Plus New Technical Developments and Innovations from Celanese.

The final agenda will be shared later this summer.

Celanese BioPolymer Solutions
The Best Packaging Solutions Begin + Return to Nature


This website uses 'cookies' to give you the best, most relevant experience. Using this website means you are Ok with this. You can change which cookies are set at any time - and find out more about them - by following this link.

Information on the processing of your personal data within the USA by Google and Marketo:
By clicking "Accept All", or selecting "Marketing" and/or "Analytical" and then clicking "Accept Selected", you also consent in accordance with Art. 49(1)(a) GDPR that your data may be processed in the USA. The USA is considered by the European Court of Justice to be a country with no adequate level of data protection according to EU standards. In particular, there is a risk that your data may be processed by US authorities for surveillance and investigation purposes, possibly without the opportunity for legal remedies. If you select “Necessary” and then click on "Accept Selected”, the transfer described above will not take place. You will find more detailed information in our privacy policy.